Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Kasai HF et al. |
Studies on high-energy collision-induced dissociation of endogenous cannabinoids: 2-arachidonoylglycerol and n-arachidonoylethanolamide in FAB-mass spectrometry. |
2006 |
Anal Sci |
pmid:16837740
|
Mechoulam R et al. |
Endocannabinoids, feeding and suckling--from our perspective. |
2006 |
Int J Obes (Lond) |
pmid:16570101
|
Matias I et al. |
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. |
2006 |
Int J Obes (Lond) |
pmid:16570107
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Guagnini F et al. |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. |
2006 |
Gut |
pmid:16423891
|
Bari M et al. |
New insights into endocannabinoid degradation and its therapeutic potential. |
2006 |
Mini Rev Med Chem |
pmid:16515464
|
Gough NR |
Focus issue: signaling lipids. |
2006 |
Sci. STKE |
pmid:16467192
|
Avraham Y et al. |
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. |
2006 |
Neurobiol. Dis. |
pmid:16102970
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Saario SM et al. |
URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain. |
2006 |
Chem. Biol. |
pmid:16931330
|
Sang N et al. |
PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. |
2006 |
J. Physiol. (Lond.) |
pmid:16484297
|
Oka S et al. |
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. |
2006 |
Eur. J. Pharmacol. |
pmid:16647054
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Malcher-Lopes R et al. |
Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. |
2006 |
J. Neurosci. |
pmid:16775153
|
Kishimoto S et al. |
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. |
2006 |
Int. Arch. Allergy Immunol. |
pmid:16772720
|
Hermann A et al. |
2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. |
2006 |
AAPS J |
pmid:16808043
|
Yoshida T et al. |
Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. |
2006 |
J. Neurosci. |
pmid:16672646
|
Sugiura T et al. |
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2006 |
Prog. Lipid Res. |
pmid:16678907
|
Katona I et al. |
Molecular composition of the endocannabinoid system at glutamatergic synapses. |
2006 |
J. Neurosci. |
pmid:16723519
|
Shiga N et al. |
Elimination of 2-arachidonoylglycerol action by direct hemoperfusion through immobilized polymyxin B fibers: an experimental study in conscious guinea pigs. |
2006 |
Ther Apher Dial |
pmid:17199882
|
McCarron RM et al. |
Endothelial-mediated regulation of cerebral microcirculation. |
2006 |
J. Physiol. Pharmacol. |
pmid:17244945
|
Parrish JC and Nichols DE |
Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism. |
2006 |
J. Neurochem. |
pmid:17010161
|
Kurabayashi M et al. |
2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. |
2005 Jan-Feb |
J Invest Surg |
pmid:15804949
|
Lambert DM and Fowler CJ |
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. |
2005 |
J. Med. Chem. |
pmid:16078824
|
Hayase T et al. |
Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. |
2005 |
Behav Pharmacol |
pmid:16148444
|
Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Gokoh M et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. |
2005 |
Biochem. J. |
pmid:15456404
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Sancho R et al. |
Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. |
2005 |
J. Immunol. |
pmid:16148147
|
Lauckner JE et al. |
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16365309
|
Hill MN et al. |
Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. |
2005 |
Eur. J. Pharmacol. |
pmid:16324692
|
Gokoh M et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes. |
2005 |
FEBS Lett. |
pmid:16288744
|
Straiker A and Mackie K |
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. |
2005 |
J. Physiol. (Lond.) |
pmid:16179366
|
Iturralde M et al. |
Characterization of the lipolytic pathways that mediate free fatty acid release during Fas/CD95-induced apoptosis. |
2005 |
Apoptosis |
pmid:16215685
|
Engeli S et al. |
Activation of the peripheral endocannabinoid system in human obesity. |
2005 |
Diabetes |
pmid:16186383
|
Safo PK and Regehr WG |
Endocannabinoids control the induction of cerebellar LTD. |
2005 |
Neuron |
pmid:16301180
|
Alger BE |
Endocannabinoid identification in the brain: studies of breakdown lead to breakthrough, and there may be NO hope. |
2005 |
Sci. STKE |
pmid:16278487
|
Rademacher DJ et al. |
Waterborne lead exposure affects brain endocannabinoid content in male but not female fathead minnows (Pimephales promelas). |
2005 |
Neurotoxicology |
pmid:15527869
|
Shoemaker JL et al. |
Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:16081674
|
Jung KM et al. |
Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. |
2005 |
Mol. Pharmacol. |
pmid:16051747
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Di S et al. |
Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. |
2005 |
J. Physiol. (Lond.) |
pmid:16239276
|
Gabbay E et al. |
Endocannabinoids and liver disease--review. |
2005 |
Liver Int. |
pmid:16162147
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|
Wagner JA et al. |
Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. |
2005 |
J. Cardiovasc. Pharmacol. |
pmid:16116341
|
McPartland JM et al. |
Cannabimimetic effects of osteopathic manipulative treatment. |
2005 |
J Am Osteopath Assoc |
pmid:16118355
|
Wahn H et al. |
The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16055511
|